FR2187316B2 - - Google Patents

Info

Publication number
FR2187316B2
FR2187316B2 FR7220391A FR7220391A FR2187316B2 FR 2187316 B2 FR2187316 B2 FR 2187316B2 FR 7220391 A FR7220391 A FR 7220391A FR 7220391 A FR7220391 A FR 7220391A FR 2187316 B2 FR2187316 B2 FR 2187316B2
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7220391A
Other languages
French (fr)
Other versions
FR2187316A2 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pierre Fabre SA
Original Assignee
Pierre Fabre SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pierre Fabre SA filed Critical Pierre Fabre SA
Priority to FR7220391A priority Critical patent/FR2187316A2/fr
Priority to BE784996A priority patent/BE784996A/xx
Priority to CH915372A priority patent/CH554838A/fr
Priority to ES404059A priority patent/ES404059A1/es
Priority to DE19722230078 priority patent/DE2230078A1/de
Priority to GB2901772A priority patent/GB1401841A/en
Publication of FR2187316A2 publication Critical patent/FR2187316A2/fr
Priority to US05/526,009 priority patent/US3941878A/en
Priority to US05/525,951 priority patent/US3940490A/en
Application granted granted Critical
Publication of FR2187316B2 publication Critical patent/FR2187316B2/fr
Granted legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/60Salicylic acid; Derivatives thereof
    • A61K31/618Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate
    • A61K31/621Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate having the hydroxy group in position 2 esterified, e.g. benorylate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/60Salicylic acid; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7220391A 1971-06-21 1972-06-05 Substd alkyl benzoates and benzamides - psychotropic agents Granted FR2187316A2 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
FR7220391A FR2187316A2 (en) 1972-06-05 1972-06-05 Substd alkyl benzoates and benzamides - psychotropic agents
BE784996A BE784996A (fr) 1971-06-21 1972-06-16 Nouveaux medicaments ayant des proprietes psychotropes
CH915372A CH554838A (fr) 1971-06-21 1972-06-19 Procede de preparation d'amides des acides cresotiniques.
DE19722230078 DE2230078A1 (de) 1971-06-21 1972-06-20 Kresotionsäure-Derivate mit psychotroper Wirkung, Verfahren zu deren Herstellung und diese Materialien enthaltende Arzneimittelzusammensetzungen
ES404059A ES404059A1 (es) 1971-06-21 1972-06-20 Procedimiento de fabricacion de amidas cresotinicas.
GB2901772A GB1401841A (en) 1971-06-21 1972-06-21 Hydroxytoluic acid derivatives processes for their preparation and pharmaceutical preparations containing them
US05/526,009 US3941878A (en) 1971-06-21 1974-11-21 Medicaments having psychotropic properties
US05/525,951 US3940490A (en) 1971-06-21 1974-11-21 Medicaments having psychotropic properties

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7220391A FR2187316A2 (en) 1972-06-05 1972-06-05 Substd alkyl benzoates and benzamides - psychotropic agents

Publications (2)

Publication Number Publication Date
FR2187316A2 FR2187316A2 (en) 1974-01-18
FR2187316B2 true FR2187316B2 (enrdf_load_stackoverflow) 1975-08-08

Family

ID=9099789

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7220391A Granted FR2187316A2 (en) 1971-06-21 1972-06-05 Substd alkyl benzoates and benzamides - psychotropic agents

Country Status (1)

Country Link
FR (1) FR2187316A2 (enrdf_load_stackoverflow)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1494221A (fr) * 1966-07-25 1967-09-08 Chimetron Sarl Sulfénylsalicylamides

Also Published As

Publication number Publication date
FR2187316A2 (en) 1974-01-18

Similar Documents

Publication Publication Date Title
FR2187316B2 (enrdf_load_stackoverflow)
AU480453A (enrdf_load_stackoverflow)
BG17878A1 (enrdf_load_stackoverflow)
BG18241A1 (enrdf_load_stackoverflow)
BG18284A1 (enrdf_load_stackoverflow)
BG18297A1 (enrdf_load_stackoverflow)
BG18348A1 (enrdf_load_stackoverflow)
CH545575A (enrdf_load_stackoverflow)
CH545656A (enrdf_load_stackoverflow)
CH554555A (enrdf_load_stackoverflow)
CH559344A5 (enrdf_load_stackoverflow)
CH559355A5 (enrdf_load_stackoverflow)
CH559359A5 (enrdf_load_stackoverflow)
CH559462A5 (enrdf_load_stackoverflow)
CH559598A5 (enrdf_load_stackoverflow)
CH559643A5 (enrdf_load_stackoverflow)
CH559669A5 (enrdf_load_stackoverflow)
CH559675A5 (enrdf_load_stackoverflow)
CH559759A5 (enrdf_load_stackoverflow)
CH559905A5 (enrdf_load_stackoverflow)
CH560467A5 (enrdf_load_stackoverflow)
CH560648A5 (enrdf_load_stackoverflow)
CH560949A5 (enrdf_load_stackoverflow)
CH561218A5 (enrdf_load_stackoverflow)
CH561420A5 (enrdf_load_stackoverflow)

Legal Events

Date Code Title Description
CA Change of address